merck fda - Search News

News

Merck, FDA and RSV

Reuters on MSN · 14h

US FDA approves Merck's RSV antibody for infants

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the company said.

CNBC on MSN · 1d

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Merck’s RSV antibody treatment for infants is approved by FDA

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

4hon MSN

Drug pricing reform talks with US government lack clarity, industry executives say

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Pharmalittle: We’re reading about a Merck shot for RSV, a lawsuit over an Arkansas PBM law, and more

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results